ESS
45
-2
JPM
67
-2
TGNA
56
-2
PCG
72
2
SCHW
58
2
CMCSA
46
-10
CF
44
-4
OI
58
-2
AMZN
52
4
RSG
45
-3
XOM
44
-4
AON
67
2
STI
7
2
STZ
44
-3
SBUX
45
5
SO
51
3
CLX
51
-2
MSFT
46
5
XEL
39
2
AIV
39
-2
ESS
45
-2
JPM
67
-2
TGNA
56
-2
PCG
72
2
SCHW
58
2
CMCSA
46
-10
CF
44
-4
OI
58
-2
AMZN
52
4
RSG
45
-3
XOM
44
-4
AON
67
2
STI
7
2
STZ
44
-3
SBUX
45
5
SO
51
3
CLX
51
-2
MSFT
46
5
XEL
39
2
AIV
39
-2
Financhill
Back

Apellis Pharmaceuticals, Inc. Vs. Viking Therapeutics, Inc. Industry Stock Comparison

Buy
53

APLS
Apellis Pharmaceuticals, Inc.

Last Price:
$24.66
Seasonality Move:
7.92%
Sell
37

VKTX
Viking Therapeutics, Inc.

Last Price:
$35.15
Seasonality Move:
33.2%
Buy
53
Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals, Inc. [APLS] share price is $24.48. The Score for APLS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Viking Therapeutics, Inc. (VKTX) is a Sell

Is Viking Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Viking Therapeutics, Inc. [VKTX] share price is $33.95. The Score for VKTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

  • The Apellis Pharmaceuticals, Inc. share price today is $24.48
    The current trend is moderately bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics, Inc.'s stock price today?

  • The Viking Therapeutics, Inc. share price today is $33.95
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.87 Buy
Relative Strength Index (14 RSI): 59.19 Buy
Chaikin Money Flow: -2667078 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.03 - 24.25) Buy
Bollinger Bands (100): (21.18 - 27.04) Buy

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.82 Buy
Relative Strength Index (14 RSI): 40.78 Sell
Chaikin Money Flow: -1768548 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.73 - 38.07) Sell
Bollinger Bands (100): (27.49 - 37.83) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.78 Sell
20-day SMA: 22.7 Buy
50-day SMA: 23.13 Buy
200-day SMA: 21.91 Buy
8-day EMA: 24.49 Sell
20-day EMA: 23.39 Buy
50-day EMA: 23.05 Buy
200-day EMA: 24.27 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.15 Sell
20-day SMA: 35.99 Sell
50-day SMA: 35.96 Sell
200-day SMA: 30.15 Buy
8-day EMA: 13.47 Buy
20-day EMA: 6.19 Buy
50-day EMA: 2.62 Buy
200-day EMA: 0.68 Buy

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.

Viking Therapeutics, Inc. Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.65 per share, and a decrease next year of $1.11 per share.

Apellis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):